Conceino is a China company. Kangxinuo Biological Co., Ltd. was registered in Tianjin Binhai New Area in 2009. It is a Sino-foreign joint venture founded by the senior managers of multinational pharmaceutical companies who have returned home, and is committed to the research, development, production and commercialization of vaccines for human use. The company now has a number of vaccine core intellectual property rights and proprietary technologies, and has established a 16 innovative vaccine product research and development pipeline in the field of 13 diseases, aiming at diseases such as pneumonia, tuberculosis, Ebola virus, meningitis, whooping cough and herpes zoster. The company has a vaccine R&D center with a building area of 6.5438+0.2 million square meters and a vaccine industrial production base of 38,000 square meters. After the base is put into production, it can supply a number of new vaccines, with an annual stock solution production capacity of about 70-80 million doses.